National Heart, Lung, and Blood Institute (NHLBI): all 1,143 studies

Page 2 of 12. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.

• Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell DiseaseActive, not recruitingNCT03077542Phase 1/2Results posted
• Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In AdultsCompletedNCT03043365Phase 2Results posted
• NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve ImplantationCompletedNCT03015194Not applicableResults posted
• Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT02996474Phase 1/2Results posted
• Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive TherapyActive, not recruitingNCT02979873Phase 2Results posted
• Study to Evaluate the Effect of Nicotinamide Riboside on ImmunityCompletedNCT02812238Not applicableResults posted
• CT COMPARE: CT Coronary Angiography to Measure Plaque ReductionTerminatedNCT02740699Phase 4Results posted
• Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)CompletedNCT02728102Phase 2Results posted
• A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLLActive, not recruitingNCT02514083Phase 2Results posted
• Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In AdultsCompletedNCT02514070Phase 2Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)CompletedNCT02440464Phase 2Results posted
• Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and CorticosteroidsTerminatedNCT02379442Phase 1/2Results posted
• Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)CompletedNCT02345850Phase 3Results posted
• Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)CompletedNCT02322320Phase 3Results posted
• Effects of Niacin Therapy on Lipoprotein Composition and FunctionCompletedNCT02322203Not applicableResults posted
• Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe ThrombocytopeniaCompletedNCT02298933Phase 2Results posted
• Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell DiseaseCompletedNCT02225132Phase 1/2Results posted
• Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)CompletedNCT02208037Phase 2Results posted
• Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant FailureActive, not recruitingNCT02105766Phase 2Results posted
• Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory SupportCompletedNCT01932294Results posted
• Extended Dosing With Eltrombopag for Severe Aplastic AnemiaCompletedNCT01891994Phase 2Results posted
• Preventing Stem Cell Transplant Complications With a Blood Separator MachineCompletedNCT01866839Phase 1/2Results posted
• Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese IndividualsCompletedNCT01862029Phase 1/2Results posted
• Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II ProtocolCompletedNCT01783990Results posted
• Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaActive, not recruitingNCT01623167Phase 1/2Results posted
• Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)CompletedNCT01585402Phase 2Results posted
• PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingNCT01500733Phase 2Results posted
• Danazol for Genetic Bone Marrow and Lung DisordersCompletedNCT01441037Phase 1/2Results posted
• Decitabine for High-Risk Sickle Cell DiseaseCompletedNCT01375608Phase 2Results posted
• Eltrombopag for Moderate Aplastic AnemiaCompletedNCT01328587Phase 2Results posted
• Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans SyndromeCompletedNCT01287078Phase 2Results posted
• Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis ObliteransCompletedNCT01273207Phase 2Results posted
• Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque RegressionCompletedNCT01212900Phase 4Results posted
• Systolic Blood Pressure Intervention TrialCompletedNCT01206062Not applicableResults posted
• Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic AnemiaCompletedNCT01193283Phase 1/2Results posted
• A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic AnemiaCompletedNCT01187017Phase 1/2Results posted
• Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLLCompletedNCT01145209Phase 2Results posted
• Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum CholesterolCompletedNCT01131299Phase 2Results posted
• Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)CompletedNCT01109004Phase 3Results posted
• Gardasil Vaccination in Post Stem Cell Transplant PatientsCompletedNCT01092195Phase 1Results posted
• A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory AsthmaCompletedNCT00994175Phase 2Results posted
• Statins for Acutely Injured Lungs From SepsisTerminatedNCT00979121Phase 3Results posted
• Haploidentical PBMC Transplant for Severe Congenital AnemiasActive, not recruitingNCT00977691Phase 1/2Results posted
• A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)CompletedNCT00961064Phase 2Results posted
• Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA TreatmentCompletedNCT00944749Phase 2Results posted
• A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia PatientsCompletedNCT00922883Phase 2Results posted
• Long-Term Effects of Hydroxyurea in Children With Sickle Cell Anemia (The BABY HUG Follow-up Study)CompletedNCT00890396Results posted
• Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell TransplantationCompletedNCT00859586Not applicableResults posted
• Long-term Oxygen Treatment TrialCompletedNCT00692198Phase 3Results posted
• Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic SyndromeCompletedNCT00604201Phase 2Results posted
• Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)CompletedNCT00542178Phase 3Results posted
• Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell DiseaseTerminatedNCT00492531Phase 2Results posted
• Peptide Vaccinations to Treat Patients With Low-Risk Myeloid CancersCompletedNCT00488592Phase 2Results posted
• Stem Cell Transplantation for Patients With Cancers of the BloodCompletedNCT00467961Phase 2Results posted
• Drug Study of Albuterol to Treat Acute Lung InjuryTerminatedNCT00434993Phase 2/3Results posted
• Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic MalignancyCompletedNCT00433745Phase 2Results posted
• Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)CompletedNCT00421174Phase 3Results posted
• Rilonacept to Improve Artery Function in Patients With AtherosclerosisCompletedNCT00417417Phase 2Results posted
• Dexamethasone to Prevent Oral Chronic Graft-versus-Host DiseaseCompletedNCT00391170Phase 2Results posted
• Methods to Enhance the Safety and Effectiveness of Stem Cell TransplantsCompletedNCT00378534Phase 2Results posted
• Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell DonorsCompletedNCT00353977Phase 2Results posted
• Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte LeukemiaCompletedNCT00345345Phase 2Results posted
• Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)CompletedNCT00329030Phase 3Results posted
• Atorvastatin to Treat Pulmonary SarcoidosisCompletedNCT00279708Phase 2Results posted
• Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
• Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan AnemiaCompletedNCT00229619Phase 2Results posted
• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)CompletedNCT00224874Phase 2Results posted
• A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic SyndromeCompletedNCT00217594Phase 2Results posted
• Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)CompletedNCT00201240Phase 2Results posted
• Alemtuzumab to Treat Severe Aplastic AnemiaCompletedNCT00195624Phase 2Results posted
• Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart NetworkCompletedNCT00113087Phase 3Results posted
• G-CSF and AMD3100 to Mobilize Stem Cells in Healthy VolunteersCompletedNCT00082329Phase 2Results posted
• Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow MalignanciesCompletedNCT00079391Phase 2Results posted
• Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)CompletedNCT00075829Phase 3Results posted
• AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for DonationCompletedNCT00075335Phase 2Results posted
• Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic AnemiaCompletedNCT00065260Phase 2Results posted
• Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital AnemiasActive, not recruitingNCT00061568Phase 1/2Results posted
• Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary SyndromeCompletedNCT00047060Phase 1/2Results posted
• Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDSCompletedNCT00025662Phase 2Results posted
• Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell AnemiaCompletedNCT00006400Phase 3Results posted
• Treatment With Octreotide in Patients With LymphangioleiomyomatosisCompletedNCT00005906Phase 2Results posted
• Specialized Blood Cell Transplants for Cancers of the Blood and Bone MarrowCompletedNCT00003838Phase 2Results posted
• A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow FailureTerminatedNCT00001962Phase 2Results posted
• Stem Cell Transplantation for Metastatic Solid TumorsTerminatedNCT00001880Phase 2Results posted
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)CompletedNCT00000620Phase 3Results posted
• Epcoritamab in Chronic Lymphocytic Leukemia and Richter SyndromeActive, not recruitingNCT06676033Phase 1
• Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota DysbiosisCompletedNCT06615986Early Phase 1
• NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility StudySuspendedNCT06479824Not applicable
• Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell DiseaseActive, not recruitingNCT05675436
• Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD)CompletedNCT05604547
• Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated CytopeniasWithdrawnNCT05509582Phase 2
• Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-ThalassemiaActive, not recruitingNCT05357482Phase 1/2
• The Effect of Inflammation in Heart FailureWithdrawnNCT05330013Phase 2
• Effect of Chronic Inflammation on Myocardial Perfusion and FunctionTerminatedNCT04870827
• Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)CompletedNCT04737720
• Anti-Inflammatory Effects of Time-Restricted FeedingCompletedNCT04728165
• Gene First Approach to Connective Tissue DiseaseCompletedNCT04664478
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of MitapivatActive, not recruitingNCT04610866Phase 1/2
• Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)CompletedNCT04603521
• COV2Base-A Rare Disease by COVID StudyCompletedNCT04564274

← National Heart, Lung, and Blood Institute (NHLBI) overview and focus areas